PAG
TLX

Private Advisor Group’s Telix Pharmaceuticals TLX Stock Holding History

Private Advisor Group’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
174,415
+128,070
+276% +$976K 0.01% 1134
2025
Q4 		$347K Buy
46,345
+4,233
+10% +$40.7K ﹤0.01% 2059
2025
Q3 		$403K Buy
42,112
+16,945
+67% +$208K ﹤0.01% 1898
2025
Q2 		$404K Buy
25,167
+15,027
+148% +$252K ﹤0.01% 1799
2025
Q1 		$170K Buy
+10,140
New +$177K ﹤0.01% 2129

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $6.97B AUM 29.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Private Advisor Group's TLX Position: Q1 2026 in Review

Private Advisor Group increased its Telix Pharmaceuticals (TLX) stake by 276% in Q1 2026, buying an estimated $976K and bringing the position to 174,415 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #1134.

Private Advisor Group first reported a position in TLX in Q1 2025 and has held it in 5 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Private Advisor Group held 174,415 shares of Telix Pharmaceuticals worth $1.67M as of Q1 2026.
  • Private Advisor Group bought 128,070 Telix Pharmaceuticals shares in Q1 2026, an estimated $976K.
  • Telix Pharmaceuticals made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #1134 holding.
  • Private Advisor Group first reported a position in Telix Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.